ClearPoint Neuro (CLPT) Cash & Equivalents Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.31% |
| Dec 31, 2025 | 17.97% |
| Sep 30, 2025 | 21.10% |
| Jun 30, 2025 | 20.95% |
| Mar 31, 2025 | -6.11% |
| Dec 31, 2024 | 28.69% |
| Sep 30, 2024 | 28.18% |
| Jun 30, 2024 | 34.50% |
| Mar 31, 2024 | 70.02% |
| Dec 31, 2023 | 49.48% |
| Sep 30, 2023 | 45.62% |
| Jun 30, 2023 | 31.66% |
| Mar 31, 2023 | 23.74% |
| Dec 31, 2022 | 24.34% |
| Dec 31, 2021 | 74.79% |
| Sep 30, 2021 | 67.04% |
| Jun 30, 2021 | 98.11% |
| Mar 31, 2021 | 78.47% |
| Dec 31, 2020 | 30.02% |
| Sep 30, 2020 | 51.26% |
| Jun 30, 2020 | 35.42% |
| Mar 31, 2020 | 21.40% |
| Dec 31, 2019 | -9.23% |
| Sep 30, 2019 | 26.90% |
| Jun 30, 2019 | 12.85% |
| Mar 31, 2019 | -15.55% |
| Dec 31, 2018 | -2.48% |
| Sep 30, 2018 | -5.91% |
| Jun 30, 2018 | -0.82% |
| Mar 31, 2018 | -3.97% |
| Dec 31, 2017 | 41.81% |
| Dec 31, 2016 | 86.88% |
| Sep 30, 2016 | 129.19% |
| Jun 30, 2016 | 27.54% |
| Mar 31, 2016 | 232.14% |